Bmc Cancer
暂无分享,去创建一个
Leila Mohammadi | Peter Devilee | Hans C van Houwelingen | H. V. van Houwelingen | P. Devilee | M. Blok | S. Verhoef | C. V. van Asperen | A. V. D. van den Ouweland | Q. Helmer | J. Oosterwijk | F. Hogervorst | M. Ligtenberg | R. Oldenburg | M. Ausems | R. B. van der Luijt | M. Vreeswijk | N. Hoogerbrugge | A. H. van der Hout | T. V. van Os | J. Gille | J. Wijnen | Marinus J Blok | Encarna Gómez García | Nicoline Hoogerbrugge | Juul T Wijnen | Maaike P Vreeswijk | Rogier Oldenburg | Ans van den Ouweland | Jan C Oosterwijk | Annemarie H van der Hout | Marjolijn Ligtenberg | Margreet G Ausems | Rob B van der Luijt | Charlotte J Dommering | Johan J Gille | Senno Verhoef | Frans B Hogervorst | Theo A van Os | Quinta Helmer | Christi J van Asperen | L. Mohammadi | C. Dommering | G. Margreet | Verhoef Senno | T. A. Van | E. G. Gómez Garcia | Johan J Gille | Rob B Nl | Luijt-R B Vanderluijt@umcutrecht Van Der | J Dommering-Cj Dommering@vumc Nl ; Charlotte | J. J. Nl | J. Gille | Nl | Nl ; Frans | Hogervorst-F Hogervorst@nki Nl | Os-T A Vanos@amc Uva Nl | Encarna Gómez | J Blok-R Blok@gen Unimaas Nl ; Marinus | Nl ; Juul | Helmer-Q Helmer@lumc Nl ; Quinta | Devilee-P Devilee@lumc Peter | Christi J Nl | Hans C Nl | Houwelingen-J C Van_Houwelingen@lumc Van
[1] P. Devilee,et al. Unclassified variants in disease-causing genes: nonuniformity of genetic testing and counselling, a proposal for guidelines , 2005, European Journal of Human Genetics.
[2] F. Couch,et al. Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. , 2004, American journal of human genetics.
[3] M. King,et al. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. , 2001, Human molecular genetics.
[4] W. Otten,et al. The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life , 2008, Psycho-oncology.
[5] Fergus J Couch,et al. A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. , 2007, American journal of human genetics.
[6] W. E. Hoogendoorn,et al. Modeling familial clustered breast cancer using published data. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[7] P. Devilee,et al. A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history , 2009, Breast Cancer Research.
[8] D. Berry,et al. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. , 1998, American journal of human genetics.
[9] Douglas F Easton,et al. Genetic evidence and integration of various data sources for classifying uncertain variants into a single model , 2008, Human mutation.
[10] Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] M. Skolnick,et al. Statement of the American Society of Clinical Oncology : Genetic testing for cancer susceptibility. Commentaries , 1996 .
[12] Andrej Sali,et al. Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis. , 2007, Cancer research.
[13] Douglas F Easton,et al. A full-likelihood method for the evaluation of causality of sequence variants from family data. , 2003, American journal of human genetics.
[14] J. Hopper,et al. Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance. , 2006, Cancer research.
[15] H. Putter,et al. Score test for detecting linkage to complex traits in selected samples , 2004, Genetic epidemiology.
[16] Kiley J. Johnson,et al. Functional assays for classification of BRCA2 variants of uncertain significance. , 2008, Cancer research.
[17] G. Parmigiani,et al. Missense mutations in disease genes: a Bayesian approach to evaluate causality. , 1998, American journal of human genetics.
[18] J. Benítez,et al. Classification of missense variants of unknown significance in BRCA1 based on clinical and tumor information , 2007, Human mutation.
[19] R. Elston,et al. A general model for the genetic analysis of pedigree data. , 1971, Human heredity.
[20] S. Antonarakis,et al. Corrigendum: Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion , 2002, Human mutation.
[21] Peter Devilee,et al. Intronic variants in BRCA1 and BRCA2 that affect RNA splicing can be reliably selected by splice‐site prediction programs , 2009, Human mutation.